The outlook of companies tied to iconic drugs like Viagra presents a nuanced investment picture. While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key territories has introduced significant volatility. Investors are now facing the effect of rival medications , diminishin